API
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

12 clusters · 13 sources · 68 days · First seen · Last updated

Iran Food and Drug Organization regulatory updates

Overview

The Food and Drug Organization of Iran continues to manage regulatory and supply chain challenges across medical, food, and cosmetic sectors. Regarding pharmaceutical logistics, Mehdi Pirsalahi reported that raw material transport costs have increased six to ten times due to shifts from air to rail and road transport, though domestic manufacturers remain at maximum capacity. While the supply of Factor XIII has been resolved, shortages of tricyclic antidepressants have been linked to transport restrictions from India.

Recent developments highlight a worsening psychiatric medication crisis. Seyyed Vahid Shariat, President of the Iranian Psychiatric Association, warned that shortages and rising costs are forcing patients to reduce dosages or discontinue treatment, potentially leading to a surge in disease relapse and increased hospitalizations. Shariat noted that certain injectable psychiatric drugs are nearly impossible to find, which may strain a healthcare system already facing a shortage of psychiatric beds. This economic pressure may also lead patients to delay medical visits, increasing risks of substance and alcohol abuse.

In consumer safety, the agency has issued immediate recall orders for FAT FAST tablets and Hemostasis powder. The FDA cited serious side effects and unauthorized therapeutic claims for FAT FAST, while Hemostasis powder, produced by Aria Teb Nik Seresht Toos, was recalled for lacking valid permits, authenticity labeling, and for the fraudulent use of another company’s name as its manufacturing site.

In the cosmetic sector, Behrouz Akbari, Deputy of the Cosmetic and Hygiene Products Directorate, noted the technical complexities of verifying halal status. Expanding on this, Mehdi Pirsalehi stated that the Halal concept now encompasses pharmaceuticals, medical equipment, dietary supplements, cosmetics, tourism, and healthcare services.

Entities

Food and Drug Administration of Iran · Iran · Shahram Shoaybi · Food and Drug Organization · Mohammad Hashemi

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [HEALTH] 2 sources
    Psychiatric drug shortages in Iran spark health concerns

    Shortages and high costs of psychiatric drugs in Iran are forcing patients to reduce medication, risking disease relapse and straining hospital capacity.

  2. [BUSINESS] 2 sources
    Iran seeks to expand Halal industry presence in global markets

    Iran aims to boost its global Halal industry footprint across sectors like medicine and cosmetics while maintaining stable domestic pharmaceutical reserves and insulin availability.

  3. [HEALTH] 2 sources
    Iran Food and Drug Administration reviews halal status of cosmetic products

    Iran's Food and Drug Administration official emphasizes the need for complex chemical and biological analysis to verify the halal status of cosmetic ingredients like collagen, gelatin, and snail extracts.

  4. [HEALTH] 2 sources
    Iran Food and Drug Administration orders recall of two unauthorized products

    The Iranian Food and Drug Administration has ordered an immediate recall of FAT FAST tablets and Hemostasis powder due to serious side effects and lack of proper authorization.

  5. [HEALTH] 2 sources
    Iran FDA warns against unauthorized sports supplement sales

    Iran's Food and Drug Administration warns against buying sports supplements from social media or gyms, citing risks of counterfeit products containing dangerous, undisclosed substances.

  6. [HEALTH] 2 sources
    Iran faces shortage of psychiatric medications

    The Iranian Psychiatric Association warns of a severe shortage of psychiatric drugs, including antidepressants and antipsychotics, due to a lack of imported raw materials for domestic production.

  7. [HEALTH] 2 sources
    Iran Food and Drug Organization identifies unauthorized cosmetics

    Iran's Food and Drug Organization has identified 21 unauthorized lip, eye, and eyebrow cosmetic products currently on the market and warned consumers to avoid them.

  8. [HEALTH] 2 sources
    Iran Food and Drug Organization addresses antidepressant shortages

    Iran’s Food and Drug Organization reports antidepressant shortages due to shipment restrictions from India and demands formal documentation for any claims regarding cheaper medicine supplies.

  9. [HEALTH] 4 sources
    Iran Food and Drug Administration addresses vaccine quality and border lab capacity

    Iran's Food and Drug Administration emphasizes that official vaccine quality decisions rely on formal regulatory processes and calls for expanded laboratory capacity at land borders to manage shifting trade.

  10. [HEALTH] 2 sources
    Iran Food and Drug Organization clarifies infant formula quota rules

    Iran's Food and Drug Organization has implemented a code-based verification system for infant formula to prevent resale and ensure supplies reach intended parents rather than profiteers.

  11. [HEALTH] 5 sources
    Iran Food and Drug Administration addresses supply chain and regulation issues

    Iran's Food and Drug Administration reports that domestic manufacturers are working 24/7 to combat rising raw material costs and supply chain shifts, while clarifying new regulations for herbal medicine sales.

  12. [HEALTH] 2 sources
    Iran Food and Drug Organization addresses medical supplies and food safety claims

    Iran's Food and Drug Organization is addressing medical glove supply stability and investigating social media claims regarding the alleged reuse of expired dairy products in manufacturing.

Sources

aftabnews.ir · asrpress.ir · chn.ir · darmanyabonline.ir · daroovasalamat.ir · ettehadkhabar.ir · gilkhabar.ir · impala.pt · iranmedicalinfo.com · khabarfoori.com · negarmag.com · rokna.net · tadbirvaomid.ir

This summary has been updated 8 times: see revision history